Literature DB >> 11440989

Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy.

C Toomes1, N J Marchbank, D A Mackey, J E Craig, R A Newbury-Ecob, C P Bennett, C J Vize, S P Desai, G C Black, N Patel, M Teimory, A F Markham, C F Inglehearn, A J Churchill.   

Abstract

Dominant optic atrophy (DOA) is the commonest form of inherited optic neuropathy. Although heterogeneous, a major locus has been mapped to chromosome 3q28 and the gene responsible, OPA1, was recently identified. We therefore screened a panel of 35 DOA patients for mutations in OPA1. This revealed 14 novel mutations and a further three known mutations, which together accounted for 20 of the 35 families (57%) included in this study. This more than doubles the number of OPA1 mutations reported in the literature, bringing the total to 25. These are predominantly null mutations generating truncated proteins, strongly suggesting that the mechanism underlying DOA is haploinsufficiency. The mutations are largely family-specific, although a common 4 bp deletion in exon 27 (eight different families) and missense mutations in exons 8 (two families) and 9 (two families) have been identified. Haplotype analysis of individuals with the exon 27 2708del(TTAG) mutation suggests that this is a mutation hotspot and not an ancient mutation, thus excluding a major founder effect at the OPA1 locus. The mutation screening in this study also identified a number of asymptomatic individuals with OPA1 mutations. A re-calculation of the penetrance of this disorder within two of our families indicates figures as low as 43 and 62% associated with the 2708del(TTAG) mutation. If haploinsufficiency is the mechanism underlying DOA it is unlikely that this figure will be mutation-specific, indicating that the penetrance in DOA is much lower than the 98% reported previously. To investigate whether Leber's hereditary optic neuropathy (LHON) could be caused by mutations in OPA1 we also screened a panel of 28 LHON patients who tested negatively for the three major LHON mutations. No mutations were identified in any LHON patients, indicating that DOA and LHON are genetically distinct.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440989     DOI: 10.1093/hmg/10.13.1369

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  Importance of molecular testing in dominant optic atrophy.

Authors:  N Patel; A J Churchill; C Toomes; N J Marchbank; C F Inglehearn; N Foulds; A Moosavi; M Teimory
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

2.  OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy.

Authors:  Tetsuya Hamahata; Takuro Fujimaki; Keiko Fujiki; Ai Miyazaki; Atsushi Mizota; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

Review 3.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

4.  Dominant retinitis pigmentosa phenotype associated with a new mutation in the splicing factor PRPF31.

Authors:  S Ghazawy; K Springell; V Gauba; M A McKibbin; C F Inglehearn
Journal:  Br J Ophthalmol       Date:  2007-10       Impact factor: 4.638

5.  Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.

Authors:  Huajin Li; Evan M Jones; Hui Li; Lizhu Yang; Zixi Sun; Zhisheng Yuan; Rui Chen; Fangtian Dong; Ruifang Sui
Journal:  Ophthalmic Genet       Date:  2018-06-28       Impact factor: 1.803

Review 6.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

7.  Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.

Authors:  M Votruba; D Thiselton; S S Bhattacharya
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

8.  A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.

Authors:  Maria Liguori; Antonella La Russa; Ida Manna; Virginia Andreoli; Manuela Caracciolo; Patrizia Spadafora; Rita Cittadella; Aldo Quattrone
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

9.  Solving a 50 year mystery of a missing OPA1 mutation: more insights from the first family diagnosed with autosomal dominant optic atrophy.

Authors:  Nico Fuhrmann; Simone Schimpf; York Kamenisch; Beate Leo-Kottler; Christiane Alexander; Georg Auburger; Eberhart Zrenner; Bernd Wissinger; Marcel V Alavi
Journal:  Mol Neurodegener       Date:  2010-06-14       Impact factor: 14.195

10.  Identification of two novel OPA1 mutations in Chinese families with autosomal dominant optic atrophy.

Authors:  Yang Li; Ting Deng; Yi Tong; Shuling Peng; Bing Dong; Dacheng He
Journal:  Mol Vis       Date:  2008-12-29       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.